Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder

P. F. Mulders; K. Miller; N. S. Tchekmedyian

For citations:

Mulders P.F., Miller K., Tchekmedyian N.S. Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder. Cancer Urology. 2008;4(1):55. (In Russ.) https://doi.org/10.17650/1726-9776-2008-4-1-55

Views PDF (Rus): 75

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy